UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
| Washington, D.C. 20549 |
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter)
|
(State or other jurisdiction of incorporation or organization) |
Commission File Number |
(I.R.S. Employer Identification Number) |
(Address of Principal Executive Offices and Zip Code)
(Issuer's telephone number)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbols | Name of Exchange on Which Registered |
| Common | AMMJ | None |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
On May 8, Joe Cleghorn stepped down from his role as Chief Executive Officer of AMMJ (the “Company”). Mr. Cleghorn will continue to serve the Company as Chairman of the Advisory Board, where he will provide strategic guidance and support to the Company’s leadership team. The Board of Directors appointed James Woodend as the Company’s new Chief Executive Officer, effective immediately. In addition, Mr. Woodend was appointed Chairman of the Board of Directors. The Company believes Mr. Woodend’s leadership, operational experience, and strategic vision will support the Company’s continued growth and long-term objectives. There were no disagreements between Mr. Cleghorn and the Company on any matter relating to the Company’s operations, policies, or practices.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMERICAN CANNABIS COMPANY, INC.
(Registrant)
By: /s/ James Woodend
Name: James Woodend
Date: May 11, 2026
Title: CEO